Role of Apoptosis in disease

Dipartimento di Scienze Biomediche, Universita' "G. d'Annunzio" Chieti-Pescara, Italy.
Aging (Impact Factor: 4.89). 05/2012; 4(5):330-49.
Source: PubMed

ABSTRACT Since the initial description of apoptosis, a number of different forms of cell death have been described. In this review we will focus on classic caspase-dependent apoptosis and its variations that contribute to diseases. Over fifty years of research have clarified molecular mechanisms involved in apoptotic signaling as well and shown that alterations of these pathways lead to human diseases. Indeed both reduced and increased apoptosis can result in pathology. More recently these findings have led to the development of therapeutic approaches based on regulation of apoptosis, some of which are in clinical trials or have entered medical practice.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes mellitus affects almost 350 million individuals throughout the globe resulting in significant morbidity and mortality. Of further concern is the growing population of individuals that remain undiagnosed but are susceptible to the detrimental outcomes of this disorder. Diabetes mellitus leads to multiple complications in the central and peripheral nervous systems that include cognitive impairment, retinal disease, neuropsychiatric disease, cerebral ischemia, and peripheral nerve degeneration. Although multiple strategies are being considered, novel targeting of trophic factors, Wnt signaling, Wnt1 inducible signaling pathway protein 1, and stem cell tissue regeneration are considered to be exciting prospects to overcome the cellular mechanisms that lead to neuronal injury in diabetes mellitus involving oxidative stress, apoptosis, and autophagy. Pathways that involve insulin-like growth factor-1, fibroblast growth factor, epidermal growth factor, and erythropoietin can govern glucose homeostasis and are intimately tied to Wnt signaling that involves Wnt1 and Wnt1 inducible signaling pathway protein 1 (CCN4) to foster control over stem cell proliferation, wound repair, cognitive decline, β-cell proliferation, vascular regeneration, and programmed cell death. Ultimately, cellular metabolism through Wnt signaling is driven by primary metabolic pathways of the mechanistic target of rapamycin and AMP activated protein kinase. These pathways offer precise biological control of cellular metabolism, but are exquisitely sensitive to the different components of Wnt signaling. As a result, unexpected clinical outcomes can ensue and therefore demand careful translation of the mechanisms that govern neural repair and regeneration in diabetes mellitus.
    Neural Regeneration Research 04/2015; 10(4):518-528. DOI:10.4103/1673-5374.155427 · 0.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A growing body of evidence supports the concept that type 3 diabetes (T3DM) is a neuroendocrine disease with abnormalities in brain glucose utilization and responsiveness to insulin and insulin-like growth factor (IGF) activation. In addition, deregulated glucose metabolism has a role in neurodegeneration and neuronal loss (usually accompanied by T3DM) along with multiple pathogenic factors including oxidative stress and mitochondrial dysfunction. Moreover, impaired insulin signaling can disturb both amyloid precursor protein (APP) processing and amyloid-beta (Aβ) clearance. This leads to increased neurotoxic effects of Aβ on neurons ending up with possible neurodegeneration and neuronal cell death. In the same context, the neuronal aging is characterized by decreased mitochondrial function and increased reactive oxygen species (ROS) production, which are associated with cognitive decline. Also, accelerated cognitive decline is associated with long-term complications. These complications are due to multifactorial factors including circulatory and metabolic considerations and recurrent hypoglycemia. Most of diabetic complications can be found in T3DM, but with increased severity. This review discusses the molecular, biochemical and cellular dysfunctions in both Alzheimer’s disease (AD) and diabetes mellitus (DM) along with the causation of neuronal loss and cell death, and so called neurodegenerative disease. Also it explains the mechanism of the crosstalk of the attenuated phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K)/Akt pathway and the intensified activation of glycogen synthase kinase-3-beta (GSK-3 β) pathway, due to trophic factor resistance, which eventually cause abnormal hyperphosphorylated tau and impaired tau gene expression proceeding neurodegeneration. Also, it discusses the relationship between T3DM and AD based on the fact that both the processing of AβPP and the clearance of Aβ are attributed to impaired insulin signaling in the brain. Additionally, it focuses on the molecular mechanism of brain insulin resistance or “T3DM” that may involve either increased serine phosphorylation of insulin receptor substrate 1 (IRS-1) protein (i.e., IRS-1 inhibition) and/or elevated degradation of IRS protein as common pathological mechanisms. Moreover, this review emphasizes on the potential link between type 2 diabetes mellitus (T2DM) and AD that might have devastating impacts on public health or healthcare systems such as socio-economic burdens. Lastly, possible biomarkers and insulin-related therapeutic strategies are suggested to help improve the early detection, diagnosis, and treatment of T3DM or AD by slowing down their progressive nature or even halt their future complications.
    04/2015, Degree: Master, Supervisor: Dr. David Albers
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The release of reactive oxygen species (ROS) and the generation of oxidative stress are considered critical factors for the pathogenesis of diabetes mellitus (DM), a disorder that is growing in prevalence and results in significant economic loss. New therapeutic directions that address the detrimental effects of oxidative stress may be especially warranted to develop effective care for the millions of individuals that currently suffer from DM. The mechanistic target of rapamycin (mTOR), silent mating type information regulation 2 homolog 1 (S. cerevisiae) (SIRT1), and Wnt1 inducible signaling pathway protein 1 (WISP1) are especially justified to be considered treatment targets for DM since these pathways can address the complex relationship between stem cells, trophic factors, impaired glucose tolerance, programmed cell death pathways of apoptosis and autophagy, tissue remodeling, cellular energy homeostasis, and vascular biology that greatly impact the biology and disease progression of DM. The translation and development of these pathways into viable therapies will require detailed understanding of their proliferative nature to maximize clinical efficacy and limit adverse effects that have the potential to lead to unintended consequences. 1. Oxidative Stress, Cellular Survival, and Programmed Cell Death Oxidative stress can significantly negatively impact cellular survival and longevity and lead to programmed cell death [1–4]. The generations of reactive oxygen species (ROS) that result in oxidative stress include nitrogen based free radical species such as nitric oxide and peroxynitrite as well as superoxide free radicals, hydrogen peroxide, and singlet oxygen [5]. ROS can result in DNA damage, mitochondrial and other organelle injury, protein misfolding, and neuronal synaptic dysfunction [6–10]. Protective pathways serve to alleviate damage from ROS and involve vitamins B, C, D, and K [11–15], coenzyme Q10 [16], glutathione peroxidase [15, 17], and superoxide dismutase [8, 9, 18–26]. Oxidative stress can lead to the induction of programmed cell death through apoptosis and autophagy [27–31]. Apop-tosis has an early phase with the loss of plasma membrane lipid phosphatidylserine (PS) asymmetry and a later phase that leads to genomic DNA degradation [32–34]. Blockade of the early phase with membrane PS externalization is vital for cellular survival since membrane PS externalization can direct inflammatory cells to engulf and remove injured cells [35–37] that may be functional and available for repair [8]. The later phase of cell death with apoptosis leads to the destruction of cellular DNA [1, 38–42]. Autophagy is another pathway of programmed cell death that permits cells to recycle cytoplasmic components while removing dysfunctional organelles for tissue remodeling [30, 34, 43–45]. Of the three categories for autophagy, microau-tophagy employs the invagination of lysosomal membranes for the sequestration and digestion of cytoplasmic components [34]. In chaperone-mediated autophagy, cytosolic chaperones transport cytoplasmic components across lysoso-mal membranes. The most prevalent category of autophagy is macroautophagy that consists of the sequestration of cytoplasmic proteins and organelles into autophagosomes. These autophagosomes then combine with lysosomes for degradation and are subsequently recycled for future cellular processes [27, 46–49].
    Oxidative medicine and cellular longevity 05/2015; 2015(875961). DOI:10.1155/2015/875961 · 3.36 Impact Factor

Full-text (3 Sources)

Available from
Jun 1, 2014